Lechleider Robert's Form 4 filing
Immunome Inc. (IMNM) · filed Jul 7, 2026
- Accession no.
- 0001997584-26-000004
- Filed
- Jul 7, 2026, 5:42 PM ET
- Trade date
- Jul 2, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.24M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lechleider RobertCIK 0001997584 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Common Stock | MOption exerciseAcquired | +55,000 | $8.73 | +$480,150 | 70,805 | Direct | |
| Jul 2, 2026 | Common Stock | SSaleDisposed | −22,714 | $21.95 | −$498,572.3 | 48,091 | Direct | |
| Jul 2, 2026 | Common Stock | SSaleDisposed | −16,214 | $22.76 | −$369,030.64 | 31,877 | Direct | |
| Jul 2, 2026 | Common Stock | SSaleDisposed | −16,072 | $23.44 | −$376,727.68 | 15,805 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Common Stock | MOption exerciseDisposed | −55,000 | $0.00 | $0 | 290,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.